UG vs. SHOT, HCWB, BGXX, AMIX, CASI, NRXP, CARA, DARE, OKYO, and ECOR
Should you be buying United-Guardian stock or one of its competitors? The main competitors of United-Guardian include Safety Shot (SHOT), HCW Biologics (HCWB), Bright Green (BGXX), Autonomix Medical (AMIX), CASI Pharmaceuticals (CASI), NRx Pharmaceuticals (NRXP), Cara Therapeutics (CARA), Daré Bioscience (DARE), OKYO Pharma (OKYO), and electroCore (ECOR). These companies are all part of the "medical" sector.
United-Guardian (NASDAQ:UG) and Safety Shot (NASDAQ:SHOT) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, community ranking, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.
United-Guardian received 182 more outperform votes than Safety Shot when rated by MarketBeat users.
United-Guardian has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. Comparatively, Safety Shot has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500.
In the previous week, Safety Shot had 13 more articles in the media than United-Guardian. MarketBeat recorded 18 mentions for Safety Shot and 5 mentions for United-Guardian. United-Guardian's average media sentiment score of 0.57 beat Safety Shot's score of 0.12 indicating that United-Guardian is being referred to more favorably in the media.
United-Guardian has higher revenue and earnings than Safety Shot. Safety Shot is trading at a lower price-to-earnings ratio than United-Guardian, indicating that it is currently the more affordable of the two stocks.
23.2% of United-Guardian shares are owned by institutional investors. Comparatively, 12.6% of Safety Shot shares are owned by institutional investors. 29.0% of United-Guardian shares are owned by insiders. Comparatively, 23.1% of Safety Shot shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
United-Guardian has a net margin of 23.77% compared to Safety Shot's net margin of -367.77%. United-Guardian's return on equity of 25.18% beat Safety Shot's return on equity.
Summary
United-Guardian beats Safety Shot on 11 of the 14 factors compared between the two stocks.
Get United-Guardian News Delivered to You Automatically
Sign up to receive the latest news and ratings for UG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding UG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
United-Guardian Competitors List
Related Companies and Tools
